Dr. Aaron Rapoport
Aaron Rapoport, M.D., professor of Medicine at the University of Maryland School of Medicine and a researcher at the University of Maryland Marlene and Stewart Greenebaum Cancer Center, has been selected by The Leukemia & Lymphoma Society to receive the Stohlman Scholar Award recognizing outstanding contributions to the advancement of blood cancer research. The awards will be officially announced at the Society’s Stohlman Scholar Scientific Symposium in Dallas on November 2 and 3.
The Stohlman award is given to Society Scholars who are in the fifth year of their research. Society Scholars are highly qualified investigators who have demonstrated their ability to conduct original research bearing on leukemia, lymphoma or myeloma and who hold faculty-level or equivalent positions at major research institutions.
Dr. Rapoport’s research is focused on immunotherapy for chronic myelogenous leukemia (CML) and multiple myeloma patients undergoing autologous stem cell transplants. Autologous transplants often fail due to the lack of immune cells (T-cells) capable of killing blood cancer cells which remain after treatment. Experiments suggest that anti-leukemic and anti-myeloma T-cells do exist in patients with these cancers, but in an inactivated state. Dr. Rapoport has been studying whether T-cells from patients with CML and myeloma can be activated in the laboratory and returned to patients to help fight their disease. Currently he is developing new post-transplant strategies which combine activated T-cells and tumor vaccines.
“The Leukemia & Lymphoma Society believes that the work of these exceptional scholars and the nearly 400 gifted scientists we are supporting around the world will result in substantial improvement in the lives of patients afflicted with leukemia, lymphoma, or myeloma,” said Marshall A. Lichtman, M.D., the Society’s Executive Vice President of Research and Medical Programs.
The Stohlman Scholar Award is given in memory of Frederick Stohlman Jr., M.D., a major figure in stem cell physiology and blood cell cancer research.
For more information, visit The Leukemia & Lymphoma Society Web site or call 800-955-4572.